Prognostic factors predicting control of chronic asthma symptoms in children receiving prophylactic bronchodilator

Insights

Asthma symptom control improved over time with bronchodilator therapy. However, a history of exacerbations due to fear, dust, or cold stimuli predicted poorer asthma symptom control in children.

Area of Science:

  • Pediatric Pulmonology
  • Allergy and Immunology

Background:

  • Chronic asthma affects a significant number of children.
  • Effective management of pediatric asthma requires understanding predictive factors for treatment success.
  • Prophylactic bronchodilator therapy is a common treatment approach.

Purpose of the Study:

  • To identify factors that predict the control of asthma symptoms in children undergoing chronic prophylactic bronchodilator therapy.
  • To evaluate the impact of specific stimuli (fear, dust, cold) on asthma symptom control over time.

Main Methods:

  • A cohort of 312 children with chronic asthma receiving prophylactic bronchodilator therapy was studied.
  • Asthma symptom control was assessed over an 18-month period.
  • Statistical analysis was used to determine the association between patient history and symptom control.

Main Results:

  • Asthma symptoms were controlled in 74.4% of patients after 18 months.
  • A history of symptom exacerbation by fear stimulus was associated with an 83.3% lower rate of control (p=0.0001).
  • A history of symptom exacerbation by dust (35.4%, p=0.003) or cold foods/drinks (71.4%, p=0.002) also predicted lower control rates.

Conclusions:

  • The duration of therapy positively influences asthma symptom control.
  • Specific triggers like fear, dust, and cold are significant predictors of poorer asthma control in children.
  • Airway lability to certain stimuli plays a crucial role in predicting treatment outcomes for pediatric asthma.

Related Concept Videos

Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...